(vardenafil HCl) Tablets
Read the Patient Information about LEVITRA before you start taking it and again each time you get a refill. There
may be new information. You may also find it helpful to share this information with your partner. This leaflet does
not take the place of talking with your doctor. You and your doctor should talk about LEVITRA when you start taking
it and at regular checkups. If you do not understand the information, or have questions, talk with your doctor or
WHAT IMPORTANT INFORMATION SHOULD YOU KNOW ABOUT LEVITRA?
LEVITRA can cause your blood pressure to drop suddenly to an unsafe level if it is taken with certain other
medicines. With a sudden drop in blood pressure, you could get dizzy, faint, or have a heart attack or
Do not take LEVITRA if you:
· take any medicines called "nitrates."
· use recreational drugs called "poppers" like amyl nitrate and
Tell all your healthcare providers that you take LEVITRA. If you need emergency medical care for a heart
problem, it will be important for your healthcare provider to know when you last took LEVITRA.
WHAT IS LEVITRA?
LEVITRA is a prescription medicine taken by mouth for the treatment of erectile dysfunction (ED) in men.
ED is a condition where the penis does not harden and expand when a man is sexually excited, or when he cannot
keep an erection. A man who has trouble getting or keeping an erection should see his doctor for help if the
condition bothers him. LEVITRA may help a man with ED get and keep an erection when he is sexually excited.
LEVITRA does not:
· cure ED
· increase a manís sexual desire
· protect a man or his partner from sexually transmitted diseases, including
HIV. Speak to your doctor about ways to guard against sexually transmitted diseases.
· serve as a male form of birth control
LEVITRA is only for men with ED. LEVITRA is not for women or children. LEVITRA must be used only under a
HOW DOES LEVITRA WORK?
When a man is sexually stimulated, his bodyís normal physical response is to increase blood flow to his
penis. This results in an erection. LEVITRA helps increase blood flow to the penis and may help men with ED get and
keep an erection satisfactory for sexual activity. Once a man has completed sexual activity, blood flow to his penis
decreases, and his erection goes away.
WHO CAN TAKE LEVITRA?
Talk to your doctor to decide if LEVITRA is right for you.
LEVITRA has been shown to be effective in men over the age of 18 years who have erectile dysfunction, including
men with diabetes or who have undergone prostatectomy.
WHO SHOULD NOT TAKE LEVITRA?
Do not take LEVITRA if you:
· take any medicines called "nitrates" . Nitrates are commonly used to
treat angina. Angina is a symptom of heart disease and can cause pain in your chest, jaw, or down your arm.
Medicines called nitrates include nitroglycerin that is found in tablets, sprays, ointments, pastes, or patches.
Nitrates can also be found in other medicines such as isosorbide dinitrate or isosorbide mononitrate. Some
recreational drugs called "poppers" also contain nitrates, such as amyl nitrate and butyl nitrate. Do not use LEVITRA
if you are using these drugs. Ask your doctor or pharmacist if you are not sure if any of your medicines are
· you have been told by your healthcare provider to not have sexual activity
because of health problems. Sexual activity can put an extra strain on your heart, especially if your heart is
already weak from a heart attack or heart disease.
· are allergic to LEVITRA or any of its ingredients. The active
ingredient in LEVITRA is called vardenafil. See the end of this leaflet for a complete list of ingredients.
WHAT SHOULD YOU DISCUSS WITH YOUR DOCTOR BEFORE TAKING LEVITRA? Before taking LEVITRA, tell your
doctor about all your medical problems, including if you:
· have heart problems such as angina, heart failure, irregular
heartbeats, or have had a heart attack. Ask your doctor if it is safe for you to have sexual activity.
· have low blood pressure or have high blood pressure that is not
· have had a stroke
· or any family members have a rare heart condition known as prolongation of
the QT interval (long QT syndrome)
· have liver problems
· have kidney problems and require dialysis
· have retinitis pigmentosa, a rare genetic (runs in families) eye
· have ever had severe vision loss, or if you have an eye condition called
non-arteritic anterior ischemic optic neuropathy (NAION)
· have stomach ulcers
· have a bleeding problem
· have a deformed penis shape or Peyronieís disease
· have had an erection that lasted more than 4 hours
· have blood cell problems such as sickle cell anemia, multiple myeloma,
CAN OTHER MEDICATIONS AFFECT LEVITRA?
Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins,
and herbal supplements. LEVITRA and other medicines may affect each other.
Always check with your doctor before starting or stopping any medicines. Especially tell your doctor if you take
any of the following:
· medicines called nitrates
· medicines called alpha-blockers. These include HytrinÒ (terazosin HCl), FlomaxÒ (tamsulosin HCl),
CarduraÒ (doxazosin mesylate), MinipressÒ (prazosin HCl) or UroxatralÒ (alfuzosin
HCl). Alpha-blockers are sometimes prescribed for prostate problems or high blood pressure. In some patients the
use of PDE5 inhibitor drugs, including LEVITRA, with alpha-blockers can lower blood pressure significantly leading
to fainting. You should contact the prescribing physician if alpha-blockers or other drugs that lower blood
pressure are prescribed by another healthcare provider.
· medicines that treat abnormal heartbeat. These include quinidine,
procainamide, amiodarone and sotalol.
· ritonavir (NorvirÒ) or indinavir
· ketoconazole or itraconazole (such as NizoralÒ or SporanoxÒ)
· other medicines or treatments for ED
HOW SHOULD YOU TAKE LEVITRA?
Take LEVITRA exactly as your doctor prescribes. LEVITRA comes in different doses (2.5 mg, 5 mg, 10 mg, and 20 mg).
For most men, the recommended starting dose is 10 mg. Take LEVITRA no more than once a day. Doses should be
taken at least 24 hours apart. Some men can only take a low dose of LEVITRA because of medical conditions or
medicines they take. Your doctor will prescribe the dose that is right for you.
· If you are older than 65 or have liver problems, your doctor may start you on
a lower dose of LEVITRA.
· If you have prostate problems or high blood pressure, for which you take
medicines called alpha-blockers, your doctor may start you on a lower dose of LEVITRA.
· If you are taking certain other medicines your doctor may prescribe a lower
starting dose and limit you to one dose of LEVITRA in a 72-hour (3 days) period.
Take 1 LEVITRA tablet about 1 hour (60 minutes) before sexual activity. Some form of sexual stimulation is needed
for an erection to happen with LEVITRA. LEVITRA may be taken with or without meals.
Do not change your dose of LEVITRA without talking to your doctor. Your doctor may lower your dose or raise your
dose, depending on how your body reacts to LEVITRA.
If you take too much LEVITRA, call your doctor or emergency room right away.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF LEVITRA?
The most common side effects with LEVITRA are headache, flushing, stuffy or runny nose, indigestion, upset
stomach, or dizziness. These side effects usually go away after a few hours. Call your doctor if you get a side
effect that bothers you or one that will not go away.
LEVITRA may uncommonly cause:
· an erection that wonít go away (priapism). If you get an
erection that lasts more than 4 hours, get medical help right away. Priapism must be treated as soon as possible or
lasting damage can happen to your penis including the inability to have erections.
· color vision changes, such as seeing a blue tinge to objects or having
difficulty telling the difference between the colors blue and green.
In rare instances, men taking PDE5 inhibitors (oral erectile dysfunction medicines, including LEVITRA) reported a
sudden decrease or loss of vision in one or both eyes. It is not possible to determine whether these events are
related directly to these medicines, to other factors such as high blood pressure or diabetes, or to a combination of
these. If you experience sudden decrease or loss of vision, stop taking PDE5 inhibitors, including LEVITRA, and call
a doctor right away.
These are not all the side effects of LEVITRA. For more information, ask your doctor or pharmacist.
HOW SHOULD LEVITRA BE STORED?
·Store LEVITRA at room temperature between 59°
and 86° F (15° to 30°
·Keep LEVITRA and all medicines out of the reach of children.
GENERAL INFORMATION ABOUT LEVITRA.
Medicines are sometimes prescribed for conditions other than those described in patient information leaflets. Do
not use LEVITRA for a condition for which it was not prescribed. Do not give LEVITRA to other people, even if they
have the same symptoms that you have. It may harm them.
This leaflet summarizes the most important information about LEVITRA. If you would like more information, talk
with your healthcare provider. You can ask your doctor or pharmacist for information about LEVITRA that is written
for health professionals.
For more information you can also visit www.LEVITRA.com, or call 1-866-LEVITRA.
WHAT ARE THE INGREDIENTS OF LEVITRA?
Active Ingredient: vardenafil hydrochloride
Inactive Ingredients: microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium
stearate, hypromellose, polyethylene glycol, titanium dioxide, yellow ferric oxide, and red ferric oxide.
orvir (ritonavir) is a trademark of Abbott Laboratories
Crixivan (indinavir sulfate) is a trademark of Merck & Co., Inc.
Nizoral (ketoconazole) is a trademark of Johnson & Johnson
Sporanox (itraconazole) is a trademark of Johnson & Johnson
Hytrin (terazosin HCl) is a trademark of Abbott Laboratories
Flomax (tamsulosin HCl) is a trademark of Yamanouchi Pharmaceutical Co., Ltd.
Cardura (doxazosin mesylate) is a trademark of Pfizer Inc.
Minipress (prazosin HCl) is a trademark of Pfizer Inc.
Uroxatral (alfuzosin HCl) is a trademark of Sanofi-Synthelabo
LEVITRA is a registered trademark of Bayer Aktiengesellschaft and is used under license by GlaxoSmithKline and